Search clinical trials for: CC-292 lenalidomide
Total 2354 results
-
The Lymphoma Academic Research OrganisationCelgene CorporationCompletedRelapsed/Refractory B-cell LymphomaFrance
-
CelgeneCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Austria
-
Philip Morris Products S.A.Completed
-
Philip Morris Products S.A.Completed
-
Philip Morris Products S.A.CompletedSmokingUnited Kingdom
-
Philip Morris Products S.A.Completed
-
Philip Morris Products S.A.Completed
-
CelgeneTerminatedLymphoma, Large B-Cell, DiffuseUnited States, France, Canada, Italy
-
Philip Morris Products S.A.Completed
-
CelgeneCompleted
-
Celgene CorporationCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Germany
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, Germany
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
CelgeneCompletedChronic Lymphocytic Leukemia | Leukemia, B-Cell, ChronicCanada, United States, Germany, Italy, Spain, Sweden, United Kingdom
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
CelgeneCompletedMultiple MyelomaUkraine, Russian Federation
-
King's College Hospital NHS TrustCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Celgene CorporationCompletedRadiculopathyUnited States
-
Celgene CorporationTerminatedComplex Regional Pain Syndrome, Type IUnited States
-
National Cancer Institute (NCI)CompletedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
Arbeitsgemeinschaft medikamentoese TumortherapieCelgene CorporationUnknownChronic Myelomonocytic LeukemiaAustria
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Thrombocytopenia | Fever | Chronic Lymphocytic Leukemia | Lymphadenopathy | Small Lymphocytic Lymphoma | Hypogammaglobulinemia | Lymphocytosis | Night Sweats | ParaproteinemiaUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruiting
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthy | Hepatic ImpairmentUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompletedHealthyUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States
-
CelgeneCompletedRheumatoid ArthritisUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyAvailableBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationSpain, United States, Australia, France, Germany, Israel, Italy, Japan, New Zealand, Poland, Singapore, Switzerland
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthy | Renal InsufficiencyUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompletedHealthyUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingCarcinoma, Non-Small-Cell LungUnited States, Denmark, Taiwan, China, Canada, Spain, Germany, Japan, United Kingdom, Brazil, India, Korea, Republic of, Australia, Italy, Norway, Israel, Greece, Turkey, Netherlands, Austria, Belgium, Hong Kong, Poland, Puerto Rico, Cz... and more
-
CelgeneCompleted
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Small Cell Lung CancerUnited States
-
Celgene CorporationCompletedCrohn's DiseaseFrance, United States, United Kingdom, Israel
-
CelgeneCompleted
-
CelgeneCompletedMultiple MyelomaUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingMedullary Thyroid CancerUnited States, Canada, Spain, China, Taiwan, Australia, Japan, India, Belgium, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, United Kingdom, Italy, Israel, Greece, Poland, Russian Federation